CB-912

N/A

Report date: 2025/01/26 19:18:12
NME

Base Information

Drug NameCB-912
Drug Alias Namecannabinoid receptor 1 antagonist (National Health Research Institutes)CB-912
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB1 receptor antagonists
TargetsCannabinoid CB1 receptor
Therapy Area/IndicationsMetabolic DiseasesAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNational Health Research Institutes
China Registration ClassN/A

Develop Information

Active CompaniesNational Health Research Institutes
Inactive CompaniesN/A
Active IndicationsMetabolic DiseasesAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A